THU., JUNE 20, 2019 | 11 AM PST

Pullan's Pieces – A Business Development View of the Oncology Landscape 

With an unprecedented number of new investigational agents and companies in today’s oncology space, it can be challenging to track and understand current oncology agents in clinical development, the clinical trials testing them, and what it means for the future.

In our June 20th webinar, biopharma partnering expert and Life Sciences consultant, Linda Pullan, PhD, will explore today’s oncology landscape and offer her perspective on trends, pipeline by indication, dealmaking, and the top ten oncology companies and the drugs they’re developing.

During Part I of this three-part webinar, Linda will discuss:

  • How today’s oncology market compares to other therapeutic areas
  • Address unmet needs
  • Who the major players are and what they are developing
  • What deals are like and the stage of development they are taking place in
  • What we can expect in the upcoming years

Please join us from your desk on June 20th as Linda provides a comprehensive overview of today’s robust oncology landscape and offers her clarity and perspectives on many of its complexities and nuances. 

If you are unable to join us and would like to access the recorded version once available, please register for the live event and we'll send you access to the recording. Register today.

Read more about Linda Pullan, PhD, below...

Register for
the Webinar



ShareVault’s secure document sharing solution gives pharmaceutical and biotechnology organizations the confidence to simply and securely share sensitive documents with third parties during due diligence, product development, technology transfers, fundraising, partnering, collaborative research and other activities that require the highest level of document security.

Compared to consumer-grade solutions, ShareVault virtual data rooms offer many features that give you control and document intelligence with the highest level of document-protection and monitoring available. Learn more.